title: Primary chemoprevention of breast cancer: Are the adverse effects too burdensome?
authors: Bloomberg School of Public Health (Prasad); Department of Biostatistics (Diener-West), Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md. vinayak.k.prasad@gmail.com.
authors: Vinay
authors: V
authors: Prasad
authors: Bloomberg School of Public Health (Prasad); Department of Biostatistics (Diener-West), Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md.
authors: Marie
authors: M
authors: Diener-West
mesh_terms: D000328:Adult; D000368:Aged; D000730:Androstadienes / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D018890:Chemoprevention; D005260:Female; D006801:Humans; D008875:Middle Aged; D018570:Risk Assessment; D013629:Tamoxifen / Q000009:adverse effects
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; D013629:Tamoxifen; C056516:exemestane